Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Procter & Gamble Co filings on SEC EDGAR ↗
Procter & Gamble CEO-Baby and Feminine Care El Hak Hesham Abd Sells $379K of Stock
El Hak Hesham Abd, CEO-Baby and Feminine Care, sold 2,250 shares of Procter & Gamble Co at $168.47 a share, worth $379K in total on Nov 12, 2026. Shares held after the trade: 8,968 (-20.1%).
Procter & Gamble CFO Andre Schulten Sells $5.18M of Stock
Andre Schulten, CFO, sold 30,677 shares of Procter & Gamble Co at $169.00 a share, worth $5.18M in total on Nov 5, 2026. Shares held after the trade: 65,618 (-31.9%).
Procter & Gamble CEO - Grooming de Azevedo Juliana Monteiro Santos Sells $908K of Stock
de Azevedo Juliana Monteiro Santos, CEO - Grooming, sold 5,370 shares of Procter & Gamble Co at $169.00 a share, worth $908K in total on Nov 5, 2026. Shares held after the trade: 21,361 (-20.1%).
The Procter & Gamble Company closed an underwritten public offering of four tranches of Euro-denominated notes totaling €3.25 billion in aggregate principal amount. The offering includes notes maturing in 2030, 2034, 2038, and 2046 with interest rates ranging from 3.750% to 4.625%.
Procter & Gamble SVP - CAO Matthew W. Janzaruk Sells $1.55M of Stock
Matthew W. Janzaruk, SVP - CAO, sold 9,479 shares of Procter & Gamble Co at $163.00 a share, worth $1.55M in total on Nov 3, 2026. Shares held after the trade: 1,271 (-88.2%).
Procter & Gamble CEO- Health Care Paul Gama Sells $478K of Stock
Paul Gama, CEO- Health Care, sold 2,894 shares of Procter & Gamble Co at $165.00 a share, worth $478K in total on Oct 30, 2026. Shares held after the trade: 43,899 (-6.2%).
Procter & Gamble Chf Rsch, Dev & Innov Officer Moses Victor Javier Aguilar Sells $3.09M of Stock
Moses Victor Javier Aguilar, Chf Rsch, Dev & Innov Officer, sold 18,812 shares of Procter & Gamble Co at $164.43 a share, worth $3.09M in total on Oct 30, 2026. Shares held after the trade: 55,243 (-25.4%).
Procter & Gamble CEO-Fabric Home & Habitat Care Sundar G. Raman Sells $6.31M of Stock
Sundar G. Raman, CEO-Fabric Home & Habitat Care, sold 38,253 shares of Procter & Gamble Co at $165.00 a share, worth $6.31M in total on Oct 30, 2026. Shares held after the trade: 47,745 (-44.5%).
The Procter & Gamble Company closed an underwritten public offering of $352.231 million in aggregate principal amount of Floating Rate Notes. The notes are due to mature on November 2, 2076, representing a long-term debt financing arrangement.
The Procter & Gamble Company closed an underwritten public offering of four tranches of senior notes totaling $4.0 billion in aggregate principal amount. The offering includes notes maturing in 2031, 2033, 2036, and 2056 with interest rates ranging from 5.125% to 5.900%.
Procter & Gamble Chairman, President and CEO Shailesh Jejurikar Sells $5.71M of Stock
Shailesh Jejurikar, Chairman, President and CEO, sold 35,000 shares of Procter & Gamble Co at $163.09 a share, worth $5.71M in total on Oct 23, 2026. Shares held after the trade: 55,391 (-38.7%).
Procter & Gamble Chief Human Resources Officer Balaji Purushothaman Sells $672K of Stock
Balaji Purushothaman, Chief Human Resources Officer, sold 4,181 shares of Procter & Gamble Co at $160.71 a share, worth $672K in total on Oct 23, 2026. Shares held after the trade: 11,296 (-27.0%).
Procter & Gamble CEO- Health Care Paul Gama Sells $698K of Stock
Paul Gama, CEO- Health Care, sold 4,331 shares of Procter & Gamble Co at $161.27 a share, worth $698K in total on Oct 23, 2026. Shares held after the trade: 46,793 (-8.5%).
Procter & Gamble reported net sales of $23.3 billion for the quarter ended September 30, 2026, a 4% increase over the prior year. Net earnings attributable to the company remained stable at $4.7 billion, with diluted earnings per share increasing slightly to $1.97. The company maintained strong cash flow from operations at $5.8 billion and returned $3.8 billion to shareholders through dividends and stock repurchases.
Procter & Gamble reported Q1 FY 2027 results with organic sales growth of 4.0%, driven by a 2.4% increase in organic volume. Core earnings per share rose 1% to $2.00, as productivity savings and topline growth helped offset increasing cost headwinds and marketing investments.
Procter & Gamble reported first quarter fiscal 2027 net sales of $23.3 billion, a 4% increase driven by organic volume growth and favorable product mix. The company maintained its full-year organic sales and EPS growth guidance while updating net sales guidance to reflect the Thorne acquisition.
Term
Q1 2027
“Our solid sales, earnings and cash results in the first quarter reflect sharpened execution of our integrated strategy. While we expect there will continue to be geopolitical and economic challenges, this strong start keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and free cash flow productivity for the fiscal year.”
Shailesh Jejurikar, Chairman of the Board, President and Chief Executive Officer